GUCY2C Human Pre-designed siRNA Set A contains three designed siRNAs for GUCY2C gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GUCY2D Human Pre-designed siRNA Set A contains three designed siRNAs for GUCY2D gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GUF1 Human Pre-designed siRNA Set A contains three designed siRNAs for GUF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GUK1 Human Pre-designed siRNA Set A contains three designed siRNAs for GUK1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GUK2 Human Pre-designed siRNA Set A contains three designed siRNAs for GUK2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GULP1 Human Pre-designed siRNA Set A contains three designed siRNAs for GULP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GUSB Human Pre-designed siRNA Set A contains three designed siRNAs for GUSB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GVSKYG-PEG2-azide (hydrochloride) is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.

GW 848687X is a selective, orally active prostaglandin EP1 receptor antagonist for the inhibition of inflammatory pain. The oral bioavailability of GW 848687X was 54% in rats and 53% in dogs. GW 848687X has a half-life of 2 hours and has inhibitory potential for both acute and chronic pain[1].

GW549390X is a dual inhibitor of Fluc and VEGFR2 with IC50 of 0.26 μM and 1.2 μM, respectively. GW549390X can bind to the ATP pocket of FLuc through the aniline side chain and is an ATP-competitive inhibitor of Fluc. GW549390X acts as a protein kinase inhibitor across ATP-dependent and -independent luciferases, with potential implications for […]

GW632046X is a Fluc (Firefly luciferase) inhibitor with an IC50 value of 0.58 µM[1].

GW694590A (UNC10112731) is a MYC protein stabilizer that increases endogenous MYC protein levels. GW694590A also targets receptor tyrosine kinases, inhibiting DDR2, KIT and PDGFRα by 81% at 1 μM. , 68% and 67%. GW694590A is a protein kinase inhibitor across ATP-dependent and -independent luciferases with potential effects on the Fluc reporter gene[1].

GW701427A is a dual inhibitor of Fluc and VEGFR2 with IC50 of 0.12 μM and 603 nM, respectively. GW701427A acts as a protein kinase inhibitor across ATP-dependent and -independent luciferases with potential implications for Fluc reporter assays[1].

GW759710A is a FLuc inhibitor (IC50: 0.73 μM)[1].

GW809897X is a dual inhibitor of Fluc and VEGFR with IC50 of 0.58 μM and 65 nM, respectively. GW809897X is a protein kinase inhibitor across ATP-dependent and -independent luciferases with potential impact on Fluc reporter assays[1].

GW814408X is a kinase chemical genome group (KCGS) compound that inhibits the AURKC kinase involved in cell cycle progression, checkpoint regulation, and cell division. GW814408X exhibits cell line-dependent toxicity, e.g., cytotoxic effects on HeLa cells. GW814408X acts as a protein kinase inhibitor across ATP-dependent and -independent luciferases with potential implications for Fluc reporter assays[1].

GXYLT1 Human Pre-designed siRNA Set A contains three designed siRNAs for GXYLT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GXYLT2 Human Pre-designed siRNA Set A contains three designed siRNAs for GXYLT2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GYG1 Human Pre-designed siRNA Set A contains three designed siRNAs for GYG1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GYG2 Human Pre-designed siRNA Set A contains three designed siRNAs for GYG2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GYPA Human Pre-designed siRNA Set A contains three designed siRNAs for GYPA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GYPB Human Pre-designed siRNA Set A contains three designed siRNAs for GYPB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GYPC Human Pre-designed siRNA Set A contains three designed siRNAs for GYPC gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GYPE Human Pre-designed siRNA Set A contains three designed siRNAs for GYPE gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GYS1 Human Pre-designed siRNA Set A contains three designed siRNAs for GYS1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GYS2 Human Pre-designed siRNA Set A contains three designed siRNAs for GYS2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GZF1 Human Pre-designed siRNA Set A contains three designed siRNAs for GZF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GZMA Human Pre-designed siRNA Set A contains three designed siRNAs for GZMA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GZMB Human Pre-designed siRNA Set A contains three designed siRNAs for GZMB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GZMH Human Pre-designed siRNA Set A contains three designed siRNAs for GZMH gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GZMK Human Pre-designed siRNA Set A contains three designed siRNAs for GZMK gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GZMM Human Pre-designed siRNA Set A contains three designed siRNAs for GZMM gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GZNL-P36 is an orally active inhibitor for SARS-CoV-2 papain-like protease (PLpro), with an IC50 of 6.45 nM. GZNL-P36 inhibits SARS-CoV and its variants with EC50 range from 58.2 nM to 2.66 μM. GZNL-P36 exhibits a peak plasma concentration Cmax of 549 ng/mL, a half-life T1/2 of 1.45 h and a bioavailability of 74.7% in CD-1 […]

GZR18 is an analog of glucagon-like peptide-1 (GLP-1), which exhibits agonistic activity for GLP-1 receptor, with an EC50 of 0.677 nM. GZR18 ameliorates type 2 diabetes[1].

Gαq/11 protein-IN-1 (compound F33) is an inhibitor of Gαq/11 protein with an IC50 value of 9.4 μM. Gαq/11 protein-IN-1 has antitumor activity[1].

H-Ala-Ala-OH (L-Alanyl-L-alanine; Ala-Ala) is a nonpolar dipeptide that is absorbed by human intestinal Caco-2 cells. The transport of alanine (Ala), like proton/amino acid symport, can lead to cytoplasmic acidification[1].

H-Ala-Ala-OH (L-Alanyl-L-alanine; Ala-Ala) is a nonpolar dipeptide that is absorbed by human intestinal Caco-2 cells. The transport of alanine (Ala), like proton/amino acid symport, can lead to cytoplasmic acidification[1].

H1-0 Human Pre-designed siRNA Set A contains three designed siRNAs for H1-0 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

H1-1 Human Pre-designed siRNA Set A contains three designed siRNAs for H1-1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

H1-10 Human Pre-designed siRNA Set A contains three designed siRNAs for H1-10 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

H1-2 Human Pre-designed siRNA Set A contains three designed siRNAs for H1-2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

H1-3 Human Pre-designed siRNA Set A contains three designed siRNAs for H1-3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

H1-4 Human Pre-designed siRNA Set A contains three designed siRNAs for H1-4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

H1-5 Human Pre-designed siRNA Set A contains three designed siRNAs for H1-5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

H1-6 Human Pre-designed siRNA Set A contains three designed siRNAs for H1-6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

H1-7 Human Pre-designed siRNA Set A contains three designed siRNAs for H1-7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

H1-8 Human Pre-designed siRNA Set A contains three designed siRNAs for H1-8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

H2AB1 Human Pre-designed siRNA Set A contains three designed siRNAs for H2AB1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

H2AC18 Human Pre-designed siRNA Set A contains three designed siRNAs for H2AC18 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.